Medicines in Northern Ireland – What you need to know.
Articles filtered by tag
Clinical Development Practices & Regulations
Our latest Industry Update for Q2 covers the latest regulatory information around COVID-19 and much more.
Nitrosamines, TOPRA, Drug Development News
Nitrosamines, TOPRA, & Drug Development News are the focus for our Q4 Industry Insights
Global Harmonisation of Clinical Trials
Global Harmonisation of Clinical Trials is the latest focus for our quarterly roundup of the regulatory landscape with news from EMA, FDA and ICH
Latest News in Clinical Development Practices and Regulations
Our latest Industry Insights focuses on Brexit and news from the regulators around the globe.
Brexit, EMA, FDA & Global Regulatory News
Our first Industry Insights of 2019 focuses on the latest regulatory developments and Brexit.
Brexit Update, Clinical Trial Data Sharing, & more
Our latest industry update covers news about Brexit, from FDA, EMA and more.
Brexit, access to medicines, data & data sharing
Our latest update from the industry reflects the ongoing uncertainty around BREXIT.
BREXIT, PATIENT PERSPECTIVES, DATA SHARING in our Industry Insights for Q2
Our latest update from the industry demonstrates the uncertainty around BREXIT.
BREXIT, ICH and Regulatory Updates for this Quarter
What’s new in clinical development practices & regulations.
Latest Regulatory Updates from Our Industry Insights Q4
Our latest release of our Industry Insights Newsletter is now available to download!